CCR Monthly Approval Report – December 2017

Products from HSBC, Lyxor, Aberdeen and others won approval, as did the first alternatives products from Carlyle Group, Oaktree Capital and Intermediate Capital Group.

This content is reserved for our licensees.

Log In Register